|
APGE Apogee Therapeutics Inc 1974640 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-85,854,000.00 |
| Balance Sheet |
|
Current Assets
|
$991,733,000.00 |
|
Assets
|
$1,335,813,000.00 |
|
Current Liabilities
|
$37,510,000.00 |
|
Liabilities
|
$141,209,000.00 |
|
Shares Out
|
75339499.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-126,950,000.00 |
|
Investing Cash Flow
|
$-417,212,000.00 |
| Market Analysis |
Market Cap
|
$10,151,997,490.25 |
|
Price
|
$134.75 |
|
PB
|
2.39 |
|
EPS
|
-1.14 |
|
FCF
|
$-132,097,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:21 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:13 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
|
|
|
2026-05-11 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APGE documents filed with the SEC.
APGE Filings
Clear
